Table 1.
Clinical characteristics of NB patients in GSE49710 (samples with survival time ≤30 days and ≥10 years have been removed).
| Characteristics | Number of cases (%) |
|---|---|
| Gender | |
| Male | 247 (58.9) |
| Female | 172 (41.1) |
| Age at Diagnosis | |
| <18 months | 246 (58.7) |
| ≥18 months | 173 (41.3) |
| MYCN Status | |
| Amplified | 90 (21.5) |
| Not Amplified | 324 (77.3) |
| N/A | 5 (1.2) |
| Risk Group | |
| High risk | 168 (40.1) |
| Intermediate or low risk | 251 (59.9) |
| INSS Stage | |
| 1 | 90 (21.5) |
| 2 | 65 (15.5) |
| 3 | 46 (11.0) |
| 4 | 168 (40.1) |
| 4s | 50 (11.9) |
| Class Label | |
| Favorable | 141 (33.7) |
| Unfavorable | 90 (21.5) |
| N/A | 188 (44.9) |
| Progression | |
| Yes | 173 (41.3) |
| No | 246 (58.7) |
| Death from Disease | |
| Yes | 103 (24.6) |
| No | 316 (75.4) |
N/A, not applicable; Class label, Maximally divergent disease courses; unfavorable, patients died despite intensive chemotherapy; favorable, patients survived without chemotherapy for at least 1000 days post-diagnosis.